These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19519414)

  • 1. Application of vibrational spectroscopy to the structural characterization of monoclonal antibody and its aggregate.
    Li CH; Li T
    Curr Pharm Biotechnol; 2009 Jun; 10(4):391-9. PubMed ID: 19519414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of protein aggregation.
    Philo JS; Arakawa T
    Curr Pharm Biotechnol; 2009 Jun; 10(4):348-51. PubMed ID: 19519409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of high hydrostatic pressure to dissociate aggregates and refold proteins.
    Seefeldt MB; Rosendahl MS; Cleland JL; Hesterberg LK
    Curr Pharm Biotechnol; 2009 Jun; 10(4):447-55. PubMed ID: 19519422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody aggregate removal by hydroxyapatite chromatography.
    Gagnon P; Beam K
    Curr Pharm Biotechnol; 2009 Jun; 10(4):440-6. PubMed ID: 19519421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggregation detection and removal biopharmaceutical proteins.
    Gagnon P; Arakawa T
    Curr Pharm Biotechnol; 2009 Jun; 10(4):347. PubMed ID: 19519408
    [No Abstract]   [Full Text] [Related]  

  • 6. Ion exchange chromatography of proteins and clearance of aggregates.
    Yigzaw Y; Hinckley P; Hewig A; Vedantham G
    Curr Pharm Biotechnol; 2009 Jun; 10(4):421-6. PubMed ID: 19519418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG aggregate removal by charged-hydrophobic mixed mode chromatography.
    Gagnon P
    Curr Pharm Biotechnol; 2009 Jun; 10(4):434-9. PubMed ID: 19519420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of protein aggregation by L-arginine.
    Lange C; Rudolph R
    Curr Pharm Biotechnol; 2009 Jun; 10(4):408-14. PubMed ID: 19519416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stress-free chromatography: IEC and HIC.
    Arakawa T; Kita Y; Ejima D
    Curr Pharm Biotechnol; 2009 Jun; 10(4):461-3. PubMed ID: 19519424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. To be excluded or to bind, that is the question: Arginine effects on proteins.
    Nakakido M; Kudou M; Arakawa T; Tsumoto K
    Curr Pharm Biotechnol; 2009 Jun; 10(4):415-20. PubMed ID: 19519417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggregates in monoclonal antibody manufacturing processes.
    Vázquez-Rey M; Lang DA
    Biotechnol Bioeng; 2011 Jul; 108(7):1494-508. PubMed ID: 21480193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stress-free chromatography: affinity chromatography.
    Arakawa T; Kita Y; Sato H; Ejima D
    Curr Pharm Biotechnol; 2009 Jun; 10(4):456-60. PubMed ID: 19519423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Separation and characterization of protein aggregates and particles by field flow fractionation.
    Cao S; Pollastrini J; Jiang Y
    Curr Pharm Biotechnol; 2009 Jun; 10(4):382-90. PubMed ID: 19519413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of additives on protein aggregation.
    Hamada H; Arakawa T; Shiraki K
    Curr Pharm Biotechnol; 2009 Jun; 10(4):400-7. PubMed ID: 19519415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonnative aggregation of an IgG1 antibody in acidic conditions: part 1. Unfolding, colloidal interactions, and formation of high-molecular-weight aggregates.
    Brummitt RK; Nesta DP; Chang L; Chase SF; Laue TM; Roberts CJ
    J Pharm Sci; 2011 Jun; 100(6):2087-103. PubMed ID: 21213308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical review of methods for size characterization of non-particulate protein aggregates.
    Philo JS
    Curr Pharm Biotechnol; 2009 Jun; 10(4):359-72. PubMed ID: 19519411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonnative aggregation of an IgG1 antibody in acidic conditions, part 2: nucleation and growth kinetics with competing growth mechanisms.
    Brummitt RK; Nesta DP; Chang L; Kroetsch AM; Roberts CJ
    J Pharm Sci; 2011 Jun; 100(6):2104-19. PubMed ID: 21213307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the relevance of local conformational stability and dynamics to the aggregation propensity of an IgG1 and IgG2 monoclonal antibodies.
    Thakkar SV; Sahni N; Joshi SB; Kerwin BA; He F; Volkin DB; Middaugh CR
    Protein Sci; 2013 Oct; 22(10):1295-305. PubMed ID: 23893936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A critical review of analytical methods for subvisible and visible particles.
    Narhi LO; Jiang Y; Cao S; Benedek K; Shnek D
    Curr Pharm Biotechnol; 2009 Jun; 10(4):373-81. PubMed ID: 19519412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a dual-wavelength size exclusion HPLC method with improved sensitivity to detect protein aggregates and its use to better characterize degradation pathways of an IgG1 monoclonal antibody.
    Bond MD; Panek ME; Zhang Z; Wang D; Mehndiratta P; Zhao H; Gunton K; Ni A; Nedved ML; Burman S; Volkin DB
    J Pharm Sci; 2010 Jun; 99(6):2582-97. PubMed ID: 20039394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.